The oral suspension supports better compliance, especially in elderly patients, post-surgical recovery cases, and those with dysphagia or swallowing difficulties
Akums Drugs & Pharmaceuticals has launched Paracetamol Oral Suspension 500mg/5ml in the Indian market. This high-strength, easy-to-administer formulation is designed to improve pain and fever management in adult and geriatric patients.
Designed for real-world convenience, this oral suspension supports better compliance, especially in elderly patients, post-surgical recovery cases, and those with dysphagia or swallowing difficulties. Compared to traditional 250mg/5ml suspensions available in the market, which require 10–20ml per dose, the new formulation minimises confusion and enhances caregiver ease with a straightforward 5ml = 500mg format—especially helpful in the homecare and community health scenarios commonly seen in the Indian market.
Sandeep Jain, Joint Managing Director, Akums Drugs & Pharmaceuticals, said, “Whether it’s for an elderly person struggling to swallow tablets or someone managing care at home, we believe this product will make treatment simpler and more comfortable. It’s another step in our journey to create accessible and thoughtful healthcare solutions for everyone.”
